China’s Rise to Global Leadership in Clinical Trials


Wednesday, December 02, 2026

Register

China’s clinical trial boom is reshaping global drug development. Its growing innovation pipeline and early-phase speed and cost advantages are drawing international attention, yet much of this innovation has still to reach patients worldwide.

Join GlobalData experts to examine China’s expanding role in clinical research, how US and European sponsors are responding, and the challenges of translating domestic trial success into international approvals.




Speakers

Still looking?

Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries

Explorer

Access more premium companies when you subscribe to Explorer